Viewing Study NCT03989466


Ignite Creation Date: 2025-12-24 @ 4:37 PM
Ignite Modification Date: 2025-12-24 @ 4:37 PM
Study NCT ID: NCT03989466
Status: COMPLETED
Last Update Posted: 2024-10-10
First Post: 2019-06-14
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Itacitinib and Alemtuzumab in Treating Patients With T-Cell Prolymphocytic Leukemia
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module